My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
ARCHIVED REPORTS_XR0005437
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
P
>
PACIFIC
>
2402
>
3500 - Local Oversight Program
>
PR0545640
>
ARCHIVED REPORTS_XR0005437
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/5/2020 2:39:02 PM
Creation date
5/5/2020 1:36:33 PM
Metadata
Fields
Template:
EHD - Public
ProgramCode
3500 - Local Oversight Program
File Section
ARCHIVED REPORTS
FileName_PostFix
XR0005437
RECORD_ID
PR0545640
PE
3528
FACILITY_ID
FA0003900
FACILITY_NAME
PACIFIC PRIDE COMMERCIAL FUEL
STREET_NUMBER
2402
STREET_NAME
PACIFIC
STREET_TYPE
AVE
City
STOCKTON
Zip
95204
APN
12506001
CURRENT_STATUS
02
SITE_LOCATION
2402 PACIFIC AVE
P_LOCATION
01
P_DISTRICT
002
QC Status
Approved
Scanner
LSauers
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
38
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
r 0 <br /> In ease of ingestion, gastric lavage with activated charcoal Can be used promptly to <br /> prevent absorption. Consideration should be given to the use of an intratracheal tube, to <br /> prevent aspiration. Individuals intoxicated by DieselFuel No 2 should be hospitalised <br /> immediately, with acute and continuing attention to neurologic and cardiopulmonary <br /> function. Positive pressure ventilation may be necessary. After the initial episode, <br /> Individuals should be followed for changes in blood variables and the delayed appearance <br /> of pulmonary edema and chemical pneumonitia. Such patients should be followed for several <br /> days or weeks for delayed effects, including bone marrow toxicity, hepatic and renal <br /> impairment. Individuals with chronic pulmonary disease will be more seriously impaired, <br /> and recovery from inhalation exposure may be complicated. In case of akin injection, <br /> prompt debridement of the wound is necessary to minimise necrosis and tissue loss <br /> EYE PROTECTION- <br /> Wear safety glasses or chemical goggles to prevent eye contact. Do not wear contact <br /> lenses when working with this substance. Have eye washing facilities readily available <br /> where eye contact can occur. <br /> SKIN PROTECTION: <br /> Wear impervious gloves and protective clothing to prevent akin contact. <br /> RESPIRATORY PROTECTION: <br /> NIOSH/MSRA approved breathing equipment must be available for non-routine and emergency <br /> use. Ventilation may be used to control or reduce airborne concentrations. <br /> BOILING POINT 160 0 C(320 F) <br /> SPECIFIC GRAVITY: 0 84-0 89 @ 60 F <br /> MELTING POINT: NA <br /> %VOLATILE, NEGLIGIBLE <br /> VAPOR PRESSURE: 0 40 MM HG @ 68 F <br /> EVAPORATION RATE(WATER-1): SLOWER <br /> VAPOR DENSITY (AIR_1): 47 <br /> VISCOSITY. 2 0 -3 6 CST @ 100 F <br /> %SOLUBILITY IN WATER: NEGLIGIBLE <br /> POUR POINT. -26 1 C (-15 F) <br /> pH: NEUTRAL <br /> APPEARANCE/ODOR:STRAW COLORED LIQUID WITH A HYDROCARBON ODOR <br /> FLASH POINT: 5440 C (130 F) <br /> AUTOIGNITION TEMPERATURE: ND <br /> FLAMMABILITY LIMITS IN AIR (%BY VOL.) LOWER: 07 UPPER: 5.0 <br />. NO - No Data AH1/CY1-1 /Page 3 of 6 <br /> NA - Not Applicable <br /> I <br /> f <br />
The URL can be used to link to this page
Your browser does not support the video tag.